Design (Testphase)
Breakout & Setup
Pocket Pivot
132
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 25 strongest hits
Pocket Pivot (O'Neil/Gil Morales): an early accumulation signal. It's a strong up day with a high close, whose daily volume is GREATER than the largest down-volume day of the last 10 trading days — all happening near the 10-day EMA. This points to institutional buying, often BEFORE the stock visibly breaks out; at the bottom of a base it signals support, and multiple pocket pivots indicate accumulation. With a liquidity filter (price > $3, average $ volume > $2M) to keep out illiquid penny stocks.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(18)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EMA (Exponential Moving Average)
- Like the simple moving average, but more recent prices carry more weight - the line follows price faster. The 21-day EMA is the standard short-term trend line for momentum traders.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Institutions (Funds & Large Holders)
- Funds, pension plans, and asset managers - they move the big money and must disclose their US holdings quarterly. When the number of funds adding to a position rises, that is called institutional accumulation: the fuel behind major trends.
- Liquidity
- How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience, Inc. | 08/12 | — | 89 8/22 | Stage 2 | D -49 | 2 of 9 | 0.9 | Biotechnology | – | — | — | Healthcare | 25.90 $ | +37.3 % | +41.2 % | +942.3 % | −11.0 % | +38.9 % | 99 | 42 | 8.0 % | 7.7 % | 1.07 | — | 0.0 | — | 3.7 | — | — | 0.0 | — | — | 0.0 % | -38.9 % | -21.7 % | 0.02 | — | -100.0 % | 0.0 % | 0.0 % | 12.7 | 82.1 % | 5.5 % | — |
| CLYM Climb Bio Inc | 08/11 | +142 % | 93 9/22 | Stage 2 | D -34 | 3 of 9 | 0.7 | Biotechnology | – | — | — | Healthcare | 12.20 $ | +207.5 % | +175.5 % | +962.5 % | −5.9 % | +65.3 % | 99 | 42 | 7.3 % | 8.2 % | 0.08 | — | 0.0 | — | 4.9 | — | — | 0.6 | — | — | 0.0 % | -30.9 % | -21.3 % | 0.00 | — | — | 0.0 % | 0.0 % | 35.4 | 66.5 % | 7.4 % | — |
| KOD Kodiak Sciences Inc | 08/12 | +137 % | 40 4/22 | Stage 2 | E -55 | 2 of 9 | 2.1 | Biotechnology | – | — | — | Healthcare | 40.90 $ | +32.5 % | +21.4 % | +891.7 % | −28.7 % | +83.8 % | 98 | 42 | 8.0 % | 7.7 % | 2.20 | — | 0.0 | — | — | — | — | -0.1 | 0.0 % | — | 0.0 % | -208.8 % | -49.1 % | — | 36.6 % | — | 0.0 % | 0.0 % | -15.7 | 99.6 % | 26.6 % | 2.3 (6) |
| SLS Sellas Life Sciences Group Inc | 08/11 | +148 % | — | Stage 2 | C +5 | 3 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 12.50 $ | +140.6 % | +444.0 % | +436.3 % | −4.8 % | -5.0 % | 98 | 50 | 12.4 % | 11.1 % | 2.43 | — | 0.0 | — | — | — | — | -1.7 | 0.0 % | — | 0.0 % | -43.6 % | -25.5 % | — | 94.1 % | -100.0 % | 0.0 % | 0.0 % | 16.0 | 27.6 % | 32.4 % | 1.0 (3) |
| WYY Widepoint C | 08/13 | +242 % | 92 10/25 | Stage 2 | C +3 | 5 of 9 | 0.2 | Information Technology Services | – | — | — | Technology | 11.60 $ | +184.4 % | +194.6 % | +459.4 % | −16.9 % | -3.5 % | 98 | 13 | 16.8 % | 12.9 % | 1.71 | — | 18.2 | 1.3 | — | 25.7 | 2.33 | 117.4 | — | 13.9 % | -1.2 % | -15.8 % | -1.6 % | — | — | +5.6 % | 0.0 % | 0.0 % | -0.1 | 18.7 % | 3.5 % | — |
| KLIC Kulicke and Soffa Industries Inc | 08/05 | +47 % | 60 6/25 | Stage 2 | B +28 | 6 of 9 | 6.9 | Semiconductor Equipment & Ma | Neutral | — | Technology | 100.10 $ | +180.3 % | +179.3 % | +270.3 % | −1.4 % | -23.9 % | 97 | 6 | 7.6 % | 6.8 % | 1.63 | 120.4 | 28.4 | 9.0 | 8.0 | 1,600.0 | 2.38 | 67.5 | 15.9 % | 49.8 % | 7.2 % | 6.4 % | 3.9 % | 0.05 | 72.3 % | -7.4 % | 0.7 % | 51.9 % | 13.9 | 93.1 % | 4.2 % | 1.4 (5) | |
| APGE Apogee Therapeutics, Inc. Common S | 08/10 | — | 68 6/22 | Stage 2 | D -30 | 4 of 9 | 10.0 | Biotechnology | – | — | — | Healthcare | 134.20 $ | +76.0 % | +69.8 % | +220.9 % | −0.4 % | -1.6 % | 96 | 42 | 6.7 % | 6.5 % | 0.33 | — | 0.0 | — | 7.9 | — | — | 0.0 | 0.0 % | — | 0.0 % | -28.5 % | -19.0 % | 0.01 | 97.1 % | — | 0.0 % | 0.0 % | 40.3 | 131.6 % | 22.0 % | 1.0 (9) |
| BLZE Backblaze Inc | 08/06 | +57 % | 62 6/25 | Stage 3 | B +16 | 5 of 9 | 0.8 | Software - Infrastructure | Uses AI | — | Technology | 13.20 $ | +150.2 % | +211.9 % | +134.3 % | −8.2 % | +2.1 % | 96 | 42 | 14.6 % | 9.7 % | 1.55 | — | 178.6 | 5.1 | — | 55.9 | — | 149.5 | — | 62.3 % | -15.0 % | -27.6 % | -5.2 % | — | — | +14.3 % | 0.0 % | 0.0 % | -0.3 | 48.9 % | 2.6 % | — | |
| MGNX MacroGenics Inc | 08/13 | -6 % | 94 9/22 | Stage 2 | D -25 | 5 of 9 | 0.3 | Biotechnology | – | — | — | Healthcare | 4.30 $ | +191.3 % | +200.0 % | +262.1 % | −8.3 % | +44.8 % | 96 | 8 | 8.1 % | 7.0 % | 1.18 | — | 61.0 | 1.9 | — | — | 0.01 | 5.6 | — | -16.2 % | -44.8 % | -140.3 % | -18.0 % | — | — | +0.8 % | 0.0 % | 0.0 % | -15.0 | 70.3 % | 7.8 % | — |
| XMTR Xometry Inc | 08/04 | +114 % | 66 8/29 | Stage 2 | B +30 | 5 of 9 | 5.1 | Industrial Distribution | – | — | — | Industrials | 100.10 $ | +54.3 % | +48.6 % | +183.3 % | −7.3 % | -3.7 % | 94 | 42 | 4.8 % | 5.7 % | 1.27 | — | 119.0 | 6.9 | 18.0 | — | — | -13.1 | -2.5 % | 39.3 % | -7.0 % | -17.5 % | -3.1 % | 1.21 | 38.1 % | +25.9 % | 0.0 % | 0.0 % | 3.0 | 96.4 % | 7.5 % | 1.4 (10) |
| STRZ Starz Entertainment LLC | — | — | — | Stage 2 | E -64 | 4 of 9 | 0.0 | Entertainment | – | — | — | Communication Services | 27.30 $ | +143.2 % | +152.5 % | +56.3 % | −9.7 % | +15.0 % | 94 | 50 | 6.8 % | 7.1 % | — | — | 3.6 | — | — | — | — | 1.7 | — | 50.7 % | -13.2 % | -34.7 % | -0.8 % | — | — | -8.2 % | 0.0 % | 0.0 % | 1.3 | 92.3 % | 3.7 % | — |
| ACRS Aclaris Therapeutics Inc | 08/06 | -17 % | 41 4/22 | Stage 2 | D -40 | 5 of 9 | 0.7 | Biotechnology | – | — | — | Healthcare | 5.60 $ | +63.5 % | +65.1 % | +244.6 % | −4.7 % | +103.7 % | 94 | 42 | 5.9 % | 5.5 % | 0.77 | — | 0.0 | 80.8 | — | — | — | 0.3 | — | -668.2 % | 0.0 % | -48.4 % | -24.7 % | — | — | -58.2 % | 0.0 % | 0.0 % | -9.9 | 79.7 % | 7.3 % | — |
| AVR Anteris Technologies Global Corp. Common Stock | 08/10 | — | 70 6/22 | Stage 2 | D -38 | 4 of 9 | 1.0 | Medical Instruments & Supplies | – | — | — | Healthcare | 8.20 $ | +106.0 % | +80.8 % | +173.7 % | −6.4 % | +55.2 % | 94 | 42 | 6.4 % | 6.9 % | 0.73 | — | 0.0 | 533.9 | — | — | — | 0.0 | — | 74.3 % | 0.0 % | -59.2 % | -34.0 % | — | — | -29.2 % | 0.0 % | 0.0 % | 20.7 | 66.1 % | 8.3 % | — |
| RCUS Arcus Biosciences Inc | 08/05 | +16 % | 40 4/22 | Stage 2 | D -34 | 0 of 9 | 3.8 | Biotechnology | Neutral | — | Healthcare | 28.20 $ | +18.3 % | +34.4 % | +233.7 % | −3.8 % | +18.2 % | 93 | 42 | 6.2 % | 6.0 % | 0.80 | — | 0.0 | 16.1 | 7.4 | — | — | 4.0 | -788.2 % | -121.6 % | -156.4 % | -70.0 % | -23.1 % | 0.22 | 52.6 % | -4.3 % | 0.0 % | 0.0 % | 1.0 | 72.4 % | 17.4 % | 1.2 (13) | |
| LASR nLIGHT Inc | 08/06 | +113 % | 73 7/25 | Stage 2 | B +43 | 7 of 9 | 3.5 | Semiconductors | – | — | — | Technology | 68.30 $ | +77.1 % | +65.4 % | +262.6 % | −28.2 % | +38.4 % | 93 | 42 | 7.4 % | 8.0 % | 2.30 | — | 123.5 | 12.2 | 8.0 | 159.5 | 1.78 | 2,776.6 | -0.5 % | 31.3 % | -5.1 % | -4.6 % | -2.3 % | 0.08 | 83.2 % | +31.6 % | 0.0 % | 0.0 % | 11.0 | 92.1 % | 4.5 % | 1.1 (7) |
| MRX Marex Group plc Ordinary Shares | 08/12 | — | 79 7/22 | Stage 2 | B +21 | 4 of 9 | 4.5 | Capital Markets | – | — | — | Financial Services | 62.60 $ | +74.6 % | +49.3 % | +72.9 % | −4.8 % | -7.8 % | 92 | 79 | 4.9 % | 4.7 % | -0.09 | 14.5 | 8.8 | 0.8 | 3.4 | — | — | 6.1 | 13.1 % | 68.9 % | 10.6 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | 1.0 % | 13.3 % | 4.2 | 75.2 % | 4.6 % | 1.1 (8) |
| NAT Nordic American Tankers Limited | — | +50 % | 98 5/10 | Stage 2 | C +9 | 7 of 9 | 1.3 | Oil & Gas Midstream | – | — | — | Energy | 6.20 $ | +102.0 % | +83.4 % | +168.5 % | −6.6 % | -4.2 % | 92 | 97 | 5.9 % | 4.4 % | -0.55 | — | 10.0 | 3.8 | — | — | 1.21 | 17.3 | 49.5 % | 46.9 % | 16.4 % | 11.4 % | 4.7 % | — | 50.6 % | -16.4 % | 15.2 % | 3.4 % | 6.0 | 50.0 % | 10.9 % | 1.7 (3) |
| IMUX Immunic Inc | 08/06 | +0 % | 70 6/22 | Stage 2 | D -45 | 5 of 9 | 0.2 | Biotechnology | – | — | — | Healthcare | 15.00 $ | +182.2 % | +163.9 % | +107.8 % | −4.4 % | +196.4 % | 92 | 42 | 6.7 % | 8.8 % | 1.38 | — | 0.0 | — | — | — | — | 0.2 | — | — | 0.0 % | -142.9 % | -65.2 % | — | — | -100.0 % | 0.0 % | 0.0 % | -2.1 | 46.9 % | 12.7 % | — |
| ROIV Roivant Sciences Ltd | 08/10 | +76 % | 38 4/22 | Stage 2 | D -13 | 3 of 9 | 23.8 | Biotechnology | Uses AI | — | — | Healthcare | 34.10 $ | +48.4 % | +54.4 % | +195.7 % | −1.9 % | +14.8 % | 91 | 2 | 3.9 % | 4.0 % | 1.11 | — | 0.0 | 2,867.0 | 5.4 | — | — | 0.7 | -14,675.1 % | -8,159.0 % | 0.0 % | -7.6 % | -14.4 % | 0.02 | 79.0 % | -71.6 % | 0.0 % | 0.0 % | 19.2 | 75.9 % | 6.1 % | 1.1 (10) |
| LIND Lindblad Expeditions Holdings Inc | 08/03 | +50 % | 43 6/31 | Stage 2 | B +32 | 8 of 9 | 1.9 | Travel Services | – | — | — | Consumer Cyclical | 27.60 $ | +78.7 % | +94.4 % | +143.1 % | −1.1 % | -9.8 % | 91 | 94 | 5.8 % | 5.4 % | 2.23 | — | 217.4 | 2.4 | 159.8 | 22.7 | — | 22.2 | 7.5 % | 46.0 % | -3.1 % | -1,946.9 % | 3.8 % | -3.50 | -19.3 % | +19.6 % | 0.0 % | 0.0 % | 1.3 | 75.0 % | 10.9 % | 1.3 (3) |
| ESOA Energy Services Of America Corp | 08/10 | +201 % | 96 13/29 | Stage 2 | B +27 | 9 of 9 | 0.3 | Engineering & Construction | Neutral | — | — | Industrials | 15.90 $ | +126.3 % | +137.4 % | +86.5 % | −6.2 % | +47.1 % | 91 | 91 | 5.3 % | 5.4 % | 1.33 | 34.4 | 25.1 | 0.8 | 4.3 | 35.9 | — | 11.7 | — | 11.9 % | 2.1 % | 13.7 % | 5.7 % | 0.46 | — | +16.8 % | 0.9 % | 24.1 % | 5.7 | 55.5 % | 2.7 % | — |
| ALKS Alkermes Plc | 08/04 | +15 % | 68 6/22 | Stage 2 | C 0 | 1 of 9 | 8.8 | Drug Manufacturers - Special | – | — | — | Healthcare | 51.70 $ | +71.8 % | +84.2 % | +72.4 % | −1.6 % | -5.0 % | 90 | 9 | 4.8 % | 4.2 % | 0.29 | 61.2 | 142.9 | 5.6 | 5.3 | 39.7 | 1.96 | 36.8 | -0.2 % | 87.5 % | 9.8 % | 9.4 % | 4.7 % | 0.90 | 41.1 % | -5.3 % | 0.0 % | 0.0 % | 4.9 | 110.5 % | 15.0 % | 1.4 (15) |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | 40 4/22 | Stage 3 | D -13 | 4 of 9 | 0.5 | Medical Devices | Neutral | — | — | Healthcare | 15.10 $ | +35.5 % | +34.1 % | +58.3 % | −40.3 % | +57.8 % | 90 | 42 | 11.6 % | 9.0 % | 1.24 | — | 12.1 | 13.4 | 28.7 | — | 0.61 | -7.1 | — | 62.3 % | -71.6 % | -149.7 % | -25.0 % | 3.38 | — | +17.8 % | 0.0 % | 0.0 % | -3.1 | 50.6 % | 17.0 % | — |
| ATLC Atlanticus Holdings Corporation | 08/06 | +51 % | 41 4/22 | Stage 2 | B +41 | 6 of 9 | 1.6 | Credit Services | Uses AI | — | Financial Services | 97.90 $ | +51.4 % | +49.6 % | +106.3 % | −2.8 % | +9.7 % | 90 | 77 | 6.3 % | 6.0 % | 2.12 | — | 6.8 | 1.3 | — | 2.0 | — | 0.0 | — | 72.4 % | 21.4 % | 21.4 % | 2.5 % | — | — | +53.3 % | 0.0 % | 0.0 % | 4.5 | 25.0 % | 22.9 % | — | |
| FSTR LB Foster Company | 08/10 | +74 % | 37 5/29 | Stage 2 | C +5 | 6 of 9 | 0.5 | Railroads | – | — | — | Industrials | 41.70 $ | +63.0 % | +59.5 % | +111.1 % | −2.6 % | -10.4 % | 90 | 4 | 3.9 % | 4.2 % | 1.14 | 43.5 | 30.4 | 0.8 | 2.7 | 13.4 | 0.36 | 13.8 | — | 21.5 % | 2.0 % | 6.4 % | 5.4 % | 0.48 | — | +1.7 % | 0.0 % | 0.0 % | 8.4 | 72.3 % | 3.0 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Pocket Pivot (O'Neil/Gil Morales): an early accumulation signal. It's a strong up day with a high close, whose daily volume is GREATER than the largest down-volume day of the last 10 trading days — all happening near the 10-day EMA. This points to institutional buying, often BEFORE the stock visibly breaks out; at the bottom of a base it signals support, and multiple pocket pivots indicate accumulation.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 132 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- ATH
- Ants
- Ben Bennett: Power of Four
- Bullish Reversal Bar
- Gap-Up (≥3%)
- Green Line Breakout
- High ADR — Hot Theme
- Inside Day
- Inside Day at Highs
- Mark Minervini: Power Play
- Oliver Kell: Bull Snorts
- Oliver Kell: Gappers
- Oops Reversal
- Pradeep Bonde: $ Breakout Bullish
- Pradeep Bonde: 4% Breakout Bullish
- Qullamaggie: Continuation Base
- Qullamaggie: Episodic Pivot
- Qullamaggie: High Tight Flag
- Strong DCR (≥80)
- Tight & Near High
- Tight Weekly Closes
- Tight Weekly Range (WCR≥90)
- Volume Surge
- Volume Surge
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.